Generate Biomedicines, Inc. Share Price

Generate Biomedicines, Inc. Share Price

NASDAQ: GENB
$9.82
-$0.65 (-6.25%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Generate Biomedicines, Inc. Stock Performance

Open
$10.49
Prev. Close
$10.47
Circuit Range
N/A
Day Range
$9.73 - $10.76
Year Range
$9.73 - $22.55
Volume
39,351
Average Traded
$9.96

Generate Biomedicines, Inc. Share Price Today

As of 18 November 2026, Generate Biomedicines, Inc.'s share price is $9.82. The stock opened at $10.49, compared to its previous close of $10.47. During today's trading session, Generate Biomedicines, Inc.'s share price traded between $9.73 and $10.76, with an average price of $10.25. Over the past 52 weeks, the stock has recorded a high of $22.55 and a low of $9.73. In terms of performance, Generate Biomedicines, Inc.'s share price has declined by 24.92% over the last six months and is down 23.55% on a year-on-year basis.

Generate Biomedicines, Inc. Share Price Chart

Line chart of the Generate Biomedicines, Inc. price trend over the selected period. The price fell overall, ranging from 9.73 to 10.76, ending at 9.82.
$9.73$10.76
L
Show Current Price
H

Generate Biomedicines, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.74
Revenue (TTM)
N/A
Return On Equity (TTM)
-58.80%
Profit Margin
N/A
Debt to Equity
0.05
Quarterly Earnings Growth YoY
N/A

Generate Biomedicines, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026Sep 2026
Revenue$7.22$6.31$4.22
Net Profit-$69.20-$67.26-$87.66
Net Profit Margin-958.45%-1065.93%-2077.25%
Income ChangeN/A2.80%-30.33%

About Generate Biomedicines, Inc.

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Generate Biomedicines, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$14.54
$9.79
-32.35%
Oct 2026
$14.85
$14.48
-3.60%
Sep 2026
$15.23
$15.02
-4.76%
Aug 2026
$13.84
$15.77
+12.56%
Jul 2026
$16.66
$14.01
-17.10%
Jun 2026
$13.05
$16.90
+29.20%
May 2026
$12.94
$13.08
+3.56%
Apr 2026
$12.72
$12.63
+1.12%
Mar 2026
$12.35
$12.49
-2.76%
Feb 2026
$15.00
$12.85
N/A

GENB Share Price FAQs